Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease

• Status: Unknown status
• Trial end date: 2019-03-31
• Target enrollment: 0
• Participant gender: All

Summary

This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Sao Paulo
• Collaborator: Fundação de Amparo à Pesquisa do Estado de São Paulo
• Treatments: Immunosuppressive Agents

Criteria

Acute Vogt-Koyanagi-Harada disease

Exclusion Criteria:

• non collaborative patient

• minimum one-year follow-up